BIOA

NASDAQ · Pharmaceuticals

Bioage Labs Inc

Small-Cap Stocks Pharmaceutical Stocks Healthcare Stocks

$11.72

+0.45 (+3.99%)

As of Aug 8, 10:14 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 12 80%

Hold 3 20%

Sell 0 0%

Price Target

Analyst Price Target +12.1% upside

Low Target $9.99

Average Target $13.14

High Target $19.07

Current Price $11.72

Current
$11.72

Target
$13.14

$9.99 $13.14 avg $19.07

Scenario Analysis

Bear Case

$9.99

-14.8%

Low target

Base Case

$13.14

+12.1%

Avg target

Bull Case

$19.07

+62.7%

High target

Risk/Reward

4.2x

Highly favorable

Price in Context

52-Week High

$25.96

-54.8% from high

52-Week Low

$4.25

+175.8% from low

Target vs 52W High

$13.14

-49.4% vs high

Next Earnings Report

Aug 12, 2026

until earnings

EPS Est: $-0.62

Earnings in 2 days. Analyst targets may shift significantly after the report.

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	38	79%	$1,330.33	+12.2%
RDY Dr. Reddy's Laboratories	Strong Sell	45	31%	—	+0.0%
JNJ Johnson & Johnson	Buy	31	71%	$299.55	+15.5%
MRK Merck & Co. Inc.	Buy	36	69%	$159.27	+23.9%
PFE Pfizer Inc.	Hold	36	39%	$33.90	+26.7%
BMY Bristol-Myers Squibb Co	Hold	35	40%	$174.50	+169.6%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-36.1%
ZTS Zoetis Inc	Hold	24	54%	$209.87	+188.8%